ES2115303T3 - Uso de compuestos de 5-tia-1,4-diazabiciclo(4.2.0)octan-3,8-dioxo en terapia antitumoral. - Google Patents
Uso de compuestos de 5-tia-1,4-diazabiciclo(4.2.0)octan-3,8-dioxo en terapia antitumoral.Info
- Publication number
- ES2115303T3 ES2115303T3 ES95114673T ES95114673T ES2115303T3 ES 2115303 T3 ES2115303 T3 ES 2115303T3 ES 95114673 T ES95114673 T ES 95114673T ES 95114673 T ES95114673 T ES 95114673T ES 2115303 T3 ES2115303 T3 ES 2115303T3
- Authority
- ES
- Spain
- Prior art keywords
- hydrogen
- diazabiciclo
- octan
- tia
- dioxo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 230000000259 anti-tumor effect Effects 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 150000002431 hydrogen Chemical class 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 208000019065 cervical carcinoma Diseases 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 abstract 1
- 125000005544 phthalimido group Chemical group 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 230000001629 suppression Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A USO DE 5-TIA-1,4-DIAZABICICLO [4.2.0]OCTANO-3,8-DIOXO DE LA FORMULA GENERAL (I) DONDE LOS RADICALES POSEEN LOS SIGUIENTES SIGNIFICADOS: R1 ES HIDROGENO, HALOGENO R2- ES HIDROGENO, HALOGENO, AMINO, PHCH2-CONH, PHOCH2-CONH, EFTALIMIDO, O-MENH-COC6-H4-CONH, 3-OCLOROFENIL-5-METIL-ISOXAZOLIL-4-CARBONIL AMINO, R3 ES HIDROGENO, ALQUILO, BENCIL, ANILLO HETEROCICLICO POR EJEMPLO ISOXAZOL, PIRAZOL, N ES 1 O 2. EN LA APLICACION , SE MUESTRAN EJEMPLOS DE LA SUPRESION ED CELULAS DE CALCINOMA DEL CERVIX DEL UTERO (HELA) MEDIANTE EL USO DE VARIOS DERIVADOS DE 5-TIA-1,4-DIAZABICICLO [4.2.0]OCATNO-3,8DIOXO.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HR940577A HRP940577B1 (en) | 1994-09-21 | 1994-09-21 | Use of 5-thia-1,4-diazabicyclo (4.2.0) octane-3,8-dioxo compounds in antitumor therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2115303T3 true ES2115303T3 (es) | 1998-06-16 |
Family
ID=10946157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES95114673T Expired - Lifetime ES2115303T3 (es) | 1994-09-21 | 1995-09-18 | Uso de compuestos de 5-tia-1,4-diazabiciclo(4.2.0)octan-3,8-dioxo en terapia antitumoral. |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0705606B1 (es) |
| JP (1) | JPH08310954A (es) |
| CN (1) | CN1127115A (es) |
| AT (1) | ATE164069T1 (es) |
| BG (1) | BG62237B1 (es) |
| CA (1) | CA2158678C (es) |
| CZ (1) | CZ285621B6 (es) |
| DE (1) | DE69501810T2 (es) |
| ES (1) | ES2115303T3 (es) |
| HR (1) | HRP940577B1 (es) |
| HU (1) | HU218287B (es) |
| RU (1) | RU2136284C1 (es) |
| SI (1) | SI9500297A (es) |
| SK (1) | SK280815B6 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101671336B (zh) * | 2009-09-23 | 2013-11-13 | 辽宁利锋科技开发有限公司 | 芳杂环并嘧啶衍生物和类似物及其制备方法和用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5598188A (en) * | 1979-01-23 | 1980-07-25 | Mitsui Toatsu Chem Inc | Novel cephalosporin and its preparation |
| JPS57171994A (en) * | 1981-04-15 | 1982-10-22 | Asahi Chem Ind Co Ltd | Novel compound |
| HRP921292A2 (en) | 1992-11-17 | 1994-08-31 | Pliva Pharm & Chem Works | 5-thia-1,4-diazabicyclo (4.2.0.)octane -3,8-dioxo analogs of beta-lactams, the process for the preparation and use thereof |
-
1994
- 1994-09-21 HR HR940577A patent/HRP940577B1/xx not_active IP Right Cessation
-
1995
- 1995-09-18 DE DE69501810T patent/DE69501810T2/de not_active Expired - Fee Related
- 1995-09-18 EP EP95114673A patent/EP0705606B1/en not_active Expired - Lifetime
- 1995-09-18 AT AT95114673T patent/ATE164069T1/de not_active IP Right Cessation
- 1995-09-18 ES ES95114673T patent/ES2115303T3/es not_active Expired - Lifetime
- 1995-09-20 CZ CZ952447A patent/CZ285621B6/cs not_active IP Right Cessation
- 1995-09-20 JP JP7241717A patent/JPH08310954A/ja active Pending
- 1995-09-20 CA CA002158678A patent/CA2158678C/en not_active Expired - Fee Related
- 1995-09-20 RU RU95116239A patent/RU2136284C1/ru active
- 1995-09-21 BG BG100020A patent/BG62237B1/bg unknown
- 1995-09-21 SI SI9500297A patent/SI9500297A/sl unknown
- 1995-09-21 HU HU9502770A patent/HU218287B/hu not_active IP Right Cessation
- 1995-09-21 SK SK1170-95A patent/SK280815B6/sk unknown
- 1995-09-21 CN CN95116888A patent/CN1127115A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0705606A1 (en) | 1996-04-10 |
| CZ244795A3 (en) | 1996-04-17 |
| JPH08310954A (ja) | 1996-11-26 |
| CZ285621B6 (cs) | 1999-10-13 |
| DE69501810D1 (de) | 1998-04-23 |
| CA2158678C (en) | 2000-04-18 |
| HRP940577A2 (en) | 1997-04-30 |
| CA2158678A1 (en) | 1996-03-22 |
| SK117095A3 (en) | 1996-09-04 |
| BG62237B1 (bg) | 1999-06-30 |
| HU9502770D0 (en) | 1995-11-28 |
| HRP940577B1 (en) | 1998-12-31 |
| SI9500297A (en) | 1996-04-30 |
| BG100020A (bg) | 1996-04-30 |
| EP0705606B1 (en) | 1998-03-18 |
| RU2136284C1 (ru) | 1999-09-10 |
| CN1127115A (zh) | 1996-07-24 |
| ATE164069T1 (de) | 1998-04-15 |
| DE69501810T2 (de) | 1998-09-24 |
| HUT74422A (en) | 1996-12-30 |
| SK280815B6 (sk) | 2000-08-14 |
| HU218287B (en) | 2000-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69716226D1 (de) | Difluoroprostaglandin-Derivate und ihre Anwendung | |
| ES8604128A1 (es) | Un procedimiento para la preparacion de nuevos derivados de bencenosulfonamida | |
| PT918776E (pt) | Sintese total de acilfulvenos antitumorais | |
| DK57492D0 (da) | Farmaceutiske praeparater af n-phenylbenzamidderivater | |
| PE34996A1 (es) | Nuevo derivado de pirrocarbazol | |
| EA199801028A1 (ru) | Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний | |
| IL67812A (en) | Indanylbenzamide derivatives,process for the preparation thereof and fungicidal compositions comprising the same | |
| ES8504731A1 (es) | Un procedimiento para preparar antra 1,9-cd-7pirazol-6(2h)-onas | |
| NO173057C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzanilidderivater | |
| ES2115303T3 (es) | Uso de compuestos de 5-tia-1,4-diazabiciclo(4.2.0)octan-3,8-dioxo en terapia antitumoral. | |
| DE3674546D1 (de) | Amidderivate. | |
| NO811185L (no) | Fremgangsmaate for fremstilling av farmakologisk aktive tiazolderivater. | |
| GB2071098B (en) | Dibenzocycloheptenylidenes and antiinflammatory compositions | |
| NO159380C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive amidazolderivater. | |
| ATE19629T1 (de) | N-substituierte derivate des tetrahydroisophthalimids. | |
| ES2077697T3 (es) | Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos. | |
| FI943360A (fi) | Propoksibentseenijohdannaisia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 705606 Country of ref document: ES |